Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1011720180110020082
International Journal of Thyroidology
2018 Volume.11 No. 2 p.82 ~ p.87
Skin-Related Toxicity of Tyrosine Kinase Inhibitor in Thyroid Cancer
Lim Dong-Jun

Abstract
Skin-related toxicity is one of the most important adverse events from multi-target tyrosine kinase inhibitor (MTKI) to treat radioiodine refractory thyroid cancer. As hand foot skin reaction can limit quality of life and therapeutic effectiveness, it is essential to cope with a variety of severity of skin-related toxicity induced by MTKI. Herein, we will discuss two representative cases of skin-related toxicities which were managed by discontinuation/reduction of therapeutic doses of MTKI and were treated by proper medication in thyroid cancer patients with distant metastasis.
KEYWORD
Thyroid neoplasms, Protein kinase inhibitors, Hand-foot syndrome
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed